New Tiny Sensors Detect Dopamine in High Resolution in Nerve Cells
Scientists have developed tiny sensors that allow the high-resolution detection of dopamine — the brain chemical messenger progressively…
Articles by Patricia Inácio, PhD
Immunotolerance Molecules Show Promise in Mouse Model of PD
Preclinical research supports the potential of small molecules that modulate the immune system to halt Parkinson’s disease (PD) progression…
Vocal Changes May Be Caused by Alpha-synuclein Clumps: Study
Insoluble clumps of the alpha-synuclein protein accumulating in the brain — a hallmark of Parkinson’s disease — can affect…
PD GENEration Now Includes 20+ Clinical Sites, Aims to Enroll 15,000
The Parkinson’s Foundation has announced a major expansion of its PD GENEration national study to make genetic testing…
AI Platform Shows Potential in Diagnosing Patients at Early Stages
PreciseDx’s artificial intelligence (AI) platform shows an ability to accurately diagnose Parkinson’s disease in people before they develop severely…
Riverside Health & Rehabilitation Center Opens Parkinson’s Program
The Riverside Health & Rehabilitation Center, an affiliate of National Health Care Associates, now has a comprehensive…
PolyCore Advances PCT-3012 to Treat Parkinson’s Without Dyskinesia
PolyCore Therapeutics has secured a seed investment to advance its lead compound PCT-3012, designed to treat motor symptoms in…
MJFF $4.8M Grant Will Support Work Targeting Brain Inflammation
Neuropore Therapies has received a $4.8 million grant from the Michael J. Fox Foundation for Parkinson’s Research (MJFF) to develop…
MJFF $4.9M Grant Advances Work Into Mitochondria as Therapy Target
Lucy Therapeutics (LucyTx) has received a $4.9 million, two-year grant from the Michael J. Fox Foundation…
MJFF Names German Neurologist as Winner of 2022 Langston Award
The Michael J. Fox Foundation (MJFF) has named Brit Mollenhauer, MD, a foundation scientific advisor, as the winner…